The 500 Dalton rule for the skin penetration of chemical compounds and drugs

Experimental Dermatology

Volumn 9, Issue 3, 2000, Pages 165-169

  Bos, Jan D ^a   Meinardi, Marcus M H M ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

Drug design; Skin; Topical drugs; Transdermal

Indexed keywords

ACICLOVIR; ASCOMYCIN; BETAMETHASONE VALERATE; CLOBETASOL PROPIONATE; CLONIDINE; CLOTRIMAZOLE; CYCLOSPORIN; DIFLUCORTOLONE VALERATE; ESTRADIOL; FENTANYL; FUSIDIC ACID; GENTAMICIN; GLYCERYL TRINITRATE; HYDROCORTISONE ACETATE; KETOCONAZOLE; MICONAZOLE; MOMETASONE FUROATE; NICOTINE; PIMECROLIMUS; SCOPOLAMINE; TACROLIMUS; TERBINAFINE; TESTOSTERONE;

ATOPIC DERMATITIS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; HUMAN; MOLECULAR WEIGHT; PSORIASIS; REVIEW; SKIN ABSORPTION; SKIN DISEASE;

ABSORPTION; ADMINISTRATION, TOPICAL; CYCLOSPORINE; DERMATITIS, ALLERGIC CONTACT; DERMATOLOGIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MOLECULAR WEIGHT; PHARMACEUTICAL PREPARATIONS; SKIN;

EID: 0034098046     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2000.009003165.x     Document Type: Review

References (21)

1. Bos J D, Das P K, Kapsenberg M L. The Skin Immune System (SIS). In: Bos J D, ed., Skin Immune System (SIS): Cutaneous Immunology and Clinical Immunodermatology, 2nd edn., Boca Raton: CRC Press, 1997: 9-16.
2. Mitragotri S, Blankschtein D, Langer R. Ultrasound-mediated transdermal protein delivery. Science 1995: 269: 850-853.
3. Prausnitz M R, Bose V G, Langer R, Weaver J C. Electroporation of mammalian skin: a new mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci 1993: 90: 10504-10508.
4. Chen T, Langer R, Weaver J C. Skin electroporation causes molecule transport across the stratum corneum through localized transport regions. J Invest Dermatol (Symp Proc) 1998: 3: 159-65.
5. Merino V, Kalia Y N, Guy R H. Transdermal therapy and diagnosis by iontophoresis. Trends Biotechnol 1997: 15: 288-290.
6. Hadgraft J, Puch W J. The selection and design of topical and transdermal agents: a review. J Invest Dermatol (Symp Proc) 1998: 3: 131-135.
7. Bos J D, Meinardi M M H M, Van Joost Th, Heule F, Powles A V, Fry L. Use of cyclosporin in psoriasis. Lancet 1989: ii: 1500-1502.
8. De Rie M A, Meinardi M M H M, Bos J D. Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis. Acta Derm Venereol (Stockh) 1991: 71: 452-454.
9. Powles A V, Baker B S, McFadden J, Rutman A J, Griffiths CEM, Fry L. Intralesional injection of cyclosporin in psoriasis. Lancet 1988: i: 537.
10. Burns M K, Ellis C N, Eisen D et al. Intralesional cyclosporine for psoriasis. Relationship of dose, tissue levels, and efficacy. Arch Dermatol 1992: 128: 786-790.
11. The European FK 506 Multicentre Psoriasis Study Group. Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. Arch Dermatol 1996: 132: 419-423.
12. Remitz A, Reitamo S, Erkko P, Granlund H, Lauerma A. A microplaque assay-based, double-blind trial to compare the efficacy of two tacrolimus ointment formulations with two active and two negative controls in patients with chronic plaque-type psoriasis. Br J Dermatol 1996: 135: 833 (abstract).
13. Zonneveld I M, Rubins A, Jablonska S et al. Topical tacrolimus (FK506) is not effective in chronic plaque psoriasis. A pilot study. Arch Dermatol 1998: 134: 1101-1102.
14. Rappersberger K, Meingassner J G, Fialla R et al. Clearing of psoriasis by a novel immunosuppressive macrolide. J Invest Dermatol 1996: 106: 701-710.
15. Mrowietz U, Graeber M, Bräutigam M et al. The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion. Br J Dermatol 1998: 139: 992-996.
16. Van Leent E J M, Graeber M, Thurston M, Wagenaar A, Spuls Ph I, Bos J D. Topical treatment with the macrolactam SDZ ASM 981 is effective in atopic dermatitis. Arch Dermatol 1998: 134: 805-809.
17. Ruzicka Th, Bieber Th, Schöpf E et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 1997: 337: 816-821.
18. Langer R. Drug delivery and targeting. Nature 1998: 392 (suppl): 5-10.
19. Schulze H-J, Mahrle G, Steigleder G K. Topical cyclosporin A in psoriasis. Br J Dermatol 1990: 122: 113-114.
20. Eisen D, Ellis C N, Duell E A, Griffiths C E M, Voorhees J J. Effect of topical cyclosporin rinse on oral lichen planus. N Engl J Med 1990: 328: 290-294.
21. Levell N J, MacLeod R I, Marks J M. Lack of effect of cyclosporin mouthwash in oral lichen planus. Lancet 1991: 337: 797-780.